ReP USP - Resultado da busca

Artigo de periodico
Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings (2016)
Aguiar, Rodrigo Barbosa de; Parise, Carolina Bellini; Souza, Carolina Rosal Teixeira; Braggion, Camila; Quintilio, Wagner; Moro, Ana Maria; Marques, Fabio Luiz Navarro; Buchpiguel, Carlos Alberto; Chammas, Roger; Moraes, Jane Zveiter de
Source: Cancer Letters. Unidade: FM
Subjects: METÁSTASE NEOPLÁSICA, MELANOMA ANIMAL, ANTICORPOS MONOCLONAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AGUIAR, Rodrigo Barbosa de et al. Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings. Cancer Letters, v. 371, n. 2, p. 151–160, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.canlet.2015.11.030. Acesso em: 10 nov. 2024.
APA
Aguiar, R. B. de, Parise, C. B., Souza, C. R. T., Braggion, C., Quintilio, W., Moro, A. M., et al. (2016). Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings. Cancer Letters, 371( 2), 151–160. doi:10.1016/j.canlet.2015.11.030
NLM
Aguiar RB de, Parise CB, Souza CRT, Braggion C, Quintilio W, Moro AM, Marques FLN, Buchpiguel CA, Chammas R, Moraes JZ de. Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings [Internet]. Cancer Letters. 2016 ; 371( 2): 151–160.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.canlet.2015.11.030
Vancouver
Aguiar RB de, Parise CB, Souza CRT, Braggion C, Quintilio W, Moro AM, Marques FLN, Buchpiguel CA, Chammas R, Moraes JZ de. Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings [Internet]. Cancer Letters. 2016 ; 371( 2): 151–160.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.canlet.2015.11.030
Artigo de periodico
Anti-cea monoclonalantibody: technetium-99m labeling and the validation process of a scintigraphic animal model with a non-cellular antigenic implant (2002)
Sapienza, Marcelo Tatit; Marques, Fabio Luiz Navarro; Okamoto, Miriam Roseli Yoshie; Hironaka, Fausto Haruki; Buchpiguel, Carlos Alberto
Source: Cellular and Molecular Biology. Unidade: FM
Subjects: ANTICORPOS MONOCLONAIS, CINTILOGRAFIA, TECNÉCIO, RADIOFARMACOLOGIA, ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAPIENZA, Marcelo Tatit et al. Anti-cea monoclonalantibody: technetium-99m labeling and the validation process of a scintigraphic animal model with a non-cellular antigenic implant. Cellular and Molecular Biology, v. 48, n. 5, p. 511-516, 2002Tradução . . Acesso em: 10 nov. 2024.
APA
Sapienza, M. T., Marques, F. L. N., Okamoto, M. R. Y., Hironaka, F. H., & Buchpiguel, C. A. (2002). Anti-cea monoclonalantibody: technetium-99m labeling and the validation process of a scintigraphic animal model with a non-cellular antigenic implant. Cellular and Molecular Biology, 48( 5), 511-516.
NLM
Sapienza MT, Marques FLN, Okamoto MRY, Hironaka FH, Buchpiguel CA. Anti-cea monoclonalantibody: technetium-99m labeling and the validation process of a scintigraphic animal model with a non-cellular antigenic implant. Cellular and Molecular Biology. 2002 ; 48( 5): 511-516.[citado 2024 nov. 10 ]
Vancouver
Sapienza MT, Marques FLN, Okamoto MRY, Hironaka FH, Buchpiguel CA. Anti-cea monoclonalantibody: technetium-99m labeling and the validation process of a scintigraphic animal model with a non-cellular antigenic implant. Cellular and Molecular Biology. 2002 ; 48( 5): 511-516.[citado 2024 nov. 10 ]
Trabalho de evento-resumo
Anti-cea monoclonal antibody: lyophilized kit production, technetium-99m labeling and the construction of a cintigraphic animal model with a non-cellular antigenic implant (2001)
Sapienza, M. T.; Marques, Fabio Luiz Navarro; Okamoto, Miriam Roseli Yoshie; Hironaka, Fausto Haruki; Buchpiguel, Carlos Alberto
Conference titles: International Symposium New Trends in Biophysics. Unidade: FM
Subjects: ANTICORPOS MONOCLONAIS, RADIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAPIENZA, M. T. et al. Anti-cea monoclonal antibody: lyophilized kit production, technetium-99m labeling and the construction of a cintigraphic animal model with a non-cellular antigenic implant. 2001, Anais.. Recife: Faculdade de Medicina, Universidade de São Paulo, 2001. . Acesso em: 10 nov. 2024.
APA
Sapienza, M. T., Marques, F. L. N., Okamoto, M. R. Y., Hironaka, F. H., & Buchpiguel, C. A. (2001). Anti-cea monoclonal antibody: lyophilized kit production, technetium-99m labeling and the construction of a cintigraphic animal model with a non-cellular antigenic implant. In . Recife: Faculdade de Medicina, Universidade de São Paulo.
NLM
Sapienza MT, Marques FLN, Okamoto MRY, Hironaka FH, Buchpiguel CA. Anti-cea monoclonal antibody: lyophilized kit production, technetium-99m labeling and the construction of a cintigraphic animal model with a non-cellular antigenic implant. 2001 ;[citado 2024 nov. 10 ]
Vancouver
Sapienza MT, Marques FLN, Okamoto MRY, Hironaka FH, Buchpiguel CA. Anti-cea monoclonal antibody: lyophilized kit production, technetium-99m labeling and the construction of a cintigraphic animal model with a non-cellular antigenic implant. 2001 ;[citado 2024 nov. 10 ]

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em